Comparison between two heart immobilising agents in patients undergoing heart surgery.
Phase 2
- Conditions
- Health Condition 1: I089- Rheumatic multiple valve disease,unspecified
- Registration Number
- CTRI/2024/03/064618
- Lead Sponsor
- Head of the Department Department of Cardiac Anesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients undergoing open heart surgery under Cardiopulmonary bypass
Exclusion Criteria
Patient refusal
Patients below age of 18 years
Congenital Cyanotic heart disease
Emergency surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improved Ejection fractionTimepoint: 1 hour after weaning from CPB
- Secondary Outcome Measures
Name Time Method Wall motion score index <br/ ><br> Blood lactate level Vasoactive-inotropic score (VISmax)Timepoint: Wall motion score index pre-CPB, 1 hour after weaning from CPB <br/ ><br>Blood lactate level pre-CPB, 1 hour after weaning from CPB then every 6 hourly up to 24 hours <br/ ><br>Vasoactive-inotropic score (VISmax) assessed at first 24 h of surgery